Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-22-000047
Filing Date
2022-11-08
Accepted
2022-11-08 16:55:56
Documents
88
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20220930.htm   iXBRL 10-Q 2669426
2 EX-31.1 opk-9302022xex311.htm EX-31.1 9415
3 EX-31.2 opk-9302022xex312.htm EX-31.2 9392
4 EX-32.1 opk-9302022xex321.htm EX-32.1 3697
5 EX-32.2 opk-9302022xex322.htm EX-32.2 3730
  Complete submission text file 0000944809-22-000047.txt   13353599

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220930.xsd EX-101.SCH 82418
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20220930_cal.xml EX-101.CAL 106959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20220930_def.xml EX-101.DEF 536062
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220930_lab.xml EX-101.LAB 1030623
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220930_pre.xml EX-101.PRE 722963
82 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220930_htm.xml XML 2528499
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 221369702
SIC: 2834 Pharmaceutical Preparations